Actavis Receives Approval For Ranitidine Syrup In The U.S.: "
Actavis U.S., the United States manufacturing and marketing division of the international generic pharmaceuticals company Actavis Group (ICEX: ACT), today announced that it has received approval from the U.S. Food & Drug Administration (FDA) to market Ranitidine Oral Solution USP. Due to Actavis's first-to-file status, the FDA has granted Actavis a 180-day marketing exclusivity that will commence with the distribution of the product in the coming weeks."
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment